Author:
Yell Nicholas,Eberth Jan M.,Alberg Anthony J.,Hung Peiyin,Schootman Mario,McLain Alexander C.,Munden Reginald F.
Abstract
Abstract
Purpose
In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons and females will benefit most from these changes, but it is unclear how the revised USPSTF recommendations will impact geographic, health-related, and other sociodemographic characteristics of those eligible.
Methods
This cross-sectional study employed data from the 2017–2020 Behavioral Risk Factor Surveillance System surveys from 23 states to compare age, gender, race, marital, sexual orientation, education, employment, comorbidity, vaccination, region, and rurality characteristics of the eligible population according to the original 2013 USPSTF recommendations with the revised 2021 USPSTF recommendations using chi-squared tests. This study compared those originally eligible to those newly eligible using the BRFSS raking-dervived weighting variable.
Results
There were 30,190 study participants. The results of this study found that eligibility increased by 62.4% due to the revised recommendations. We found that the recommendation changes increased the proportion of eligible females (50.1% vs 44.1%), Black persons (9.2% vs 6.6%), Hispanic persons (4.4% vs 2.7%), persons aged 55–64 (55.8% vs 52.6%), urban-dwellers(88.3% vs 85.9%), unmarried (3.4% vs 2.5%) and never married (10.4% vs 6.6%) persons, as well as non-retirees (76.5% vs 56.1%) Respondents without comorbidities and COPD also increased.
Conclusion
It is estimated that the revision of the lung cancer screening recommendations decreased eligibility disparities in sex, race, ethnicity, marital status, respiratory comorbidities, and vaccination status. Research will be necessary to estimate whether uptake patterns subsequently follow the expanded eligibility patterns.
Funder
University of South Carolina
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. American Cancer Society (2024) Cancer Facts & Figures, https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.html. Accessed 19 February 2024
2. Surveillance, Epidemiology, and End Results. Cancer of the Lung and Bronchus—Cancer Stat Facts. https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 1 May 2023
3. National Lung Screening Trial Research, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409
4. de Koning HJ, van der Aalst CM, de Jong PA et al (2020) reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382(6):503–513. https://doi.org/10.1056/NEJMoa1911793
5. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening for Lung Cancer. U.S. Preventive Services Task Force (2021) https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/lung-cancer-newsbulletin.pdf Accessed 24 October 2022